Prediction of preeclampsia using combination of biomarkers at 18-23 weeks of gestation: A nested case-control study
ConclusionAt 18-23 weeks, Combination of CD62e microparticles, copeptin and PlGF levels can effectively identify women at risk of developing PE later in gestation.
Source: Pregnancy Hypertension: An International Journal of Womens Cardiovascular Health - Category: OBGYN Source Type: research
More News: Cardiology | Cardiovascular | Heart | Hypertension | OBGYN | Pregnancy | Statistics | Study | Women